BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32173177)

  • 1. Functional analysis of young patients with desmoid-type fibromatosis: Initial surveillance does not jeopardize long term quality of life.
    Duhil de Bénazé G; Vigan M; Corradini N; Minard-Colin V; Marie-Cardine A; Verite C; Defachelles AS; Thebaud E; Castex MP; Sirvent N; Bodet D; Mansuy L; Rome A; Petit A; Plantaz D; Jourdain A; Mary P; Carton M; Orbach D
    Eur J Surg Oncol; 2020 Jul; 46(7):1294-1300. PubMed ID: 32173177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmoid-type fibromatosis of the head and neck in children: A changing situation.
    Paul A; Blouin MJ; Minard-Colin V; Galmiche L; Coulomb A; Corradini N; Boutroux H; Van den Abbeele T; Leboulanger N; Denoyelle F; Garabedian EN; Couloigner V; Orbach D
    Int J Pediatr Otorhinolaryngol; 2019 Aug; 123():33-37. PubMed ID: 31059930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group.
    Penel N; Le Cesne A; Bonvalot S; Giraud A; Bompas E; Rios M; Salas S; Isambert N; Boudou-Rouquette P; Honore C; Italiano A; Ray-Coquard I; Piperno-Neumann S; Gouin F; Bertucci F; Ryckewaert T; Kurtz JE; Ducimetiere F; Coindre JM; Blay JY
    Eur J Cancer; 2017 Sep; 83():125-131. PubMed ID: 28735069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Event-free survival in Desmoid-Type fibromatosis (DTF): A pre-post comparison of upfront surgery versus wait-and-see approach.
    Ruspi L; Cananzi FCM; Sicoli F; Samà L; Renne SL; Marrari A; Gennaro N; Colombo P; Cozzaglio L; Politi LS; Bertuzzi A; Quagliuolo V
    Eur J Surg Oncol; 2021 May; 47(5):1196-1200. PubMed ID: 32847695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EpSSG NRSTS 2005 treatment protocol for desmoid-type fibromatosis in children: an international prospective case series.
    Orbach D; Brennan B; Bisogno G; Van Noesel M; Minard-Colin V; Daragjati J; Casanova M; Corradini N; Zanetti I; De Salvo GL; Defachelles AS; Kelsey A; Arush MB; Francotte N; Ferrari A
    Lancet Child Adolesc Health; 2017 Dec; 1(4):284-292. PubMed ID: 30169184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the best front-line approach in patients with desmoid fibromatosis? - A retrospective analysis from a reference center.
    Sobczuk P; Agnieszczak IM; Grycuk W; Czarnecka AM; Świtaj T; Koseła-Paterczyk H; Morysiński T; Zdzienicki M; Rutkowski P
    Eur J Surg Oncol; 2021 Oct; 47(10):2602-2608. PubMed ID: 33994241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desmoid fibromatosis in children and adolescents: a conservative approach to management.
    Honeyman JN; Theilen TM; Knowles MA; McGlynn MM; Hameed M; Meyers P; Crago AM; La Quaglia MP
    J Pediatr Surg; 2013 Jan; 48(1):62-6. PubMed ID: 23331794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailored Beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic intervention.
    van Broekhoven DL; Grünhagenl DJ; van Dalen T; van Coevorden F; Bonenkamp HJ; Been LB; Bemelmans MH; Dijkstra SD; Colombo C; Gronchi A; Verhoef C
    BMC Cancer; 2016 Aug; 16(1):686. PubMed ID: 27565718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical symptom burden in patients with desmoid-type fibromatosis and its impact on health-related quality of life and healthcare use.
    Schut AW; de Bruin LE; de Rooij BH; Lidington E; Timbergen MJM; van der Graaf WTA; van Houdt WJ; Bonenkamp JJ; Jones RL; Grünhagen DJ; Sleijfer S; Gennatas S; Verhoef C; Husson O
    Cancer Med; 2023 Jun; 12(12):13661-13674. PubMed ID: 37119048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmoid-Type Fibromatosis: Who, When, and How to Treat.
    Martínez Trufero J; Pajares Bernad I; Torres Ramón I; Hernando Cubero J; Pazo Cid R
    Curr Treat Options Oncol; 2017 May; 18(5):29. PubMed ID: 28439797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related Quality of Life of Patients With Non-Intra-abdominal Desmoid-Type Fibromatosis During Active Surveillance: Results of a Prospective Observational Study.
    Schut AW; Timbergen MJM; Nasserinejad K; van Dalen T; van Houdt WJ; Bonenkamp JJ; Sleijfer S; Grünhagen DJ; Verhoef C; Husson O;
    Ann Surg; 2023 Jun; 277(6):877-883. PubMed ID: 36727954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmoid-Type Fibromatosis: Evolving Treatment Standards.
    Fiore M; MacNeill A; Gronchi A; Colombo C
    Surg Oncol Clin N Am; 2016 Oct; 25(4):803-26. PubMed ID: 27591500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical excision versus observation as initial management of desmoid tumors: A population based study.
    Turner B; Alghamdi M; Henning JW; Kurien E; Morris D; Bouchard-Fortier A; Schiller D; Puloski S; Monument M; Itani D; Mack LA
    Eur J Surg Oncol; 2019 Apr; 45(4):699-703. PubMed ID: 30420189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmoid fibromatosis: is the current picture changing?
    Pandrowala S; Jones RL; Gupta S; Gulia A
    Future Oncol; 2021 Sep; 17(25):3397-3408. PubMed ID: 34227399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wait-and-see policy as a first-line management for extra-abdominal desmoid tumors.
    Briand S; Barbier O; Biau D; Bertrand-Vasseur A; Larousserie F; Anract P; Gouin F
    J Bone Joint Surg Am; 2014 Apr; 96(8):631-8. PubMed ID: 24740659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients.
    Bonvalot S; Eldweny H; Haddad V; Rimareix F; Missenard G; Oberlin O; Vanel D; Terrier P; Blay JY; Le Cesne A; Le Péchoux C
    Eur J Surg Oncol; 2008 Apr; 34(4):462-8. PubMed ID: 17709227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoid tumors: need for an individualized approach.
    de Bree E; Keus R; Melissas J; Tsiftsis D; van Coevorden F
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):525-35. PubMed ID: 19374605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors influencing event-free survival and treatments in desmoid-type fibromatosis: analysis from a large institution.
    Huang K; Wang CM; Chen JG; Du CY; Zhou Y; Shi YQ; Fu H
    Am J Surg; 2014 Jun; 207(6):847-54. PubMed ID: 24119719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmoid tumors of the head and neck: a therapeutic challenge.
    de Bree E; Zoras O; Hunt JL; Takes RP; Suárez C; Mendenhall WM; Hinni ML; Rodrigo JP; Shaha AR; Rinaldo A; Ferlito A; de Bree R
    Head Neck; 2014 Oct; 36(10):1517-26. PubMed ID: 24421052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.